- Apresentações
- Documentos
- Infográficos
Emerging Markets
guestbaefb5
•
Há 15 anos
Six sigma
Ayush Mathur
•
Há 7 anos
Regulatory Affairs.
Naila Kanwal
•
Há 8 anos
Validation master plan
Dr. Amsavel A
•
Há 5 anos
Concept of URS,DQ,IQ,OQ,PQ
dhavalrock24
•
Há 10 anos
Pharmaceutical Quality by Design (QbD)
Md. Zakaria Faruki
•
Há 5 anos
Committee for orphan medicinal products
EURORDIS Rare Diseases Europe
•
Há 6 anos
Cmc postapproval regulatory affairs (ppt)
suresh gautam
•
Há 5 anos
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Disease Drugs: Updated and Opportunities
Canadian Organization for Rare Disorders
•
Há 8 anos
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now and what is yet to come : Liz-Anne Gillham-Eisen (Health Canada)
Canadian Organization for Rare Disorders
•
Há 7 anos
Update: National Plans for Rare Diseases
Canadian Organization for Rare Disorders
•
Há 9 anos
Submitting electronic Drug Master Files (DMF) and Active Substance Master Files (ASMF)
eCTDconsultancy
•
Há 6 anos
Drug master file
Bindu Kshtriya
•
Há 7 anos
ORPHAN DRUGS- ACTS, PAST AND CURRENT SCENARIO, WITH UPCOMING DRUGS
Ashish Bajaj
•
Há 9 anos
Regulatory requirements for orphan drugs delivery
Prof. Dr. Basavaraj Nanjwade
•
Há 9 anos
Orphan drugs presentation
Atul Rajpara
•
Há 8 anos
Orphan Drugs
ANCY JOSE
•
Há 9 anos
Premarket Notification The 510(k) Process
Michael Swit
•
Há 6 anos
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
vasanthi chodavarapu
•
Há 7 anos
INSPECTION OF DRUG DISTRIBUTION CHANNELS
OORATHI SASIVARDHAN
•
Há 7 anos